Literature DB >> 1737398

Induction of covalent DNA adducts in rodents by tamoxifen.

X L Han1, J G Liehr.   

Abstract

The antiestrogen tamoxifen, increasingly used as adjuvant treatment for breast cancer, has been found to covalently modify DNA of rodents. For instance, the liver DNA of female Sprague-Dawley rats treated with a single injection of tamoxifen contained two DNA adducts. Four additional DNA adducts were formed and adduct concentrations increased 5- 7- and 10-15-fold after three and six tamoxifen injections, respectively, from levels observed after a single dose. The accumulation of DNA adducts with repeated administrations of tamoxifen to rodents may make this drug a poor choice for the chronic preventative treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737398

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Gynaecological effects of tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

2.  Restricted entry to the tamoxifen trial.

Authors:  D A Rees
Journal:  BMJ       Date:  1992-03-28

3.  Therapeutic potential of riboflavin, niacin and ascorbic acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.

Authors:  Sengodan Sundravel; Palanivel Shanthi; Panchanadham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

4.  Cells of renin lineage take on a podocyte phenotype in aging nephropathy.

Authors:  Jeffrey W Pippin; Sean T Glenn; Ronald D Krofft; Michael E Rusiniak; Charles E Alpers; Kelly Hudkins; Jeremy S Duffield; Kenneth W Gross; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

5.  Combined efficacy of tamoxifen and coenzyme Q10 on the status of lipid peroxidation and antioxidants in DMBA induced breast cancer.

Authors:  Selvanathan Saravana Perumal; Palanivelu Shanthi; Panchanadham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

Review 6.  Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer.

Authors:  L R Wiseman; K L Goa
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 7.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

8.  Pathology of endometrium treated with tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

9.  Species differences in the metabolic activation of tamoxifen into genotoxic derivatives: risk assessment in women.

Authors:  F De Matteis; I N White; L L Smith
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

Review 10.  Tamoxifen as adjuvant therapy in breast cancer. Current status.

Authors:  P N Plowman
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.